CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00896493
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:10.820263+00:00
- Published At
- 2023-05-11T00:00:00+00:00
- Record Updated At
- 2023-05-11
- Results Posted At
- 2023-05-11
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Mycoses", "Sezary Syndrome", "Lymphoma, T-Cell, Cutaneous", "Bone Marrow Transplant Failure", "Lymphoma, Non-Hodgkin", "Cutaneous T-cell Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-11"- protocolSection.identificationModule.nctId
"NCT00896493"- protocolSection.identificationModule.officialTitle
"A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-05-11"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.